Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Series A-1 Preferred
Series S-1 Preferred
Common Stock
Common Stock
RSU's
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Deficit
Beginning balance (in shares) at Dec. 31, 2022   222,588 100,000          
Beginning balance at Dec. 31, 2022 $ 2,307 $ 0 $ 0 $ 2   $ 45,748 $ (42,822) $ (621)
Beginning balance (in shares) at Dec. 31, 2022       3,150,230        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share based compensation 8         8    
Common stock issued for equity financing (in shares)       361,000        
Common stock issued for equity financing 369     $ 1   368    
Common stock issued for legal settlement (in shares)       103,707        
Common stock issued for legal settlement 170         170    
Other comprehensive income 621             621
Net income (loss) 10,085           10,085  
Ending balance (in shares) at Apr. 01, 2023   222,588 100,000          
Ending balance at Apr. 01, 2023 13,560 $ 0 $ 0 $ 3   46,294 (32,737) 0
Ending balance (in shares) at Apr. 01, 2023       3,614,937        
Beginning balance (in shares) at Dec. 31, 2023   193,730 100,000          
Beginning balance at Dec. 31, 2023 $ (3,308) $ 0 $ 0 $ 3   47,323 (50,634) 0
Beginning balance (in shares) at Dec. 31, 2023 4,957,647     4,957,647        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share based compensation $ 345         345    
Reclassification of Series S stock to liability (339)         (339)    
Reclassification of Series S stock to permanent equity 7,993              
Common stock issued for equity financing (in shares)       884,880        
Common stock issued for equity financing 627     $ 1   626    
Common stock issued for consulting agreement (in shares)       200,000        
Common stock issued for consulting agreement 232         232    
Common stock issued in lieu of professional services (in shares)       600,000        
Common stock issued in lieu of note payable obligations 367     $ 1   366    
Common stock issued for RSU's granted (in shares)         908,852      
Net income (loss) (2,144)           (2,144)  
Ending balance (in shares) at Mar. 30, 2024   193,730 100,000          
Ending balance at Mar. 30, 2024 $ 3,773 $ 0 $ 0 $ 5   $ 48,553 $ (52,778) $ 0
Ending balance (in shares) at Mar. 30, 2024 7,551,379     7,551,379